Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

Add To Watchlist

Bullboard (TSX:TH)

View:

Comment by Trogarzonon Apr 15, 2024 9:18am

RE:RE:RE:RE:Nothing does it for Thera

Sort One Corp.....

Discussion

Comment by Trogarzonon Apr 15, 2024 9:02am

RE:RE:RE:Nothing does it for Thera

Or Last Re-Sort.... or Sort-ez moi de l......

Discussion

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

Comment by Mannequinon Apr 15, 2024 8:51am

RE:RE:Nothing does it for Thera

Sort Corp

Discussion

Comment by Trogarzonon Apr 15, 2024 7:48am

RE:Nothing does it for Thera

They need to be merged with a good operator and have their pariah name erased from our memory if we ever want to get something for our gone investments. We are closing in on May 9 and like it ...more

Discussion

Post by Trogarzonon Apr 15, 2024 7:28am

Nothing does it for Thera

Read the posters and they are very good and summarize very well the state of the Th1902 program and its clinical effects. Still nobody wants to buy the stock. Long term rock solid ...more

143

Discussion

Post by Mannequinon Apr 11, 2024 3:13pm

Get a deal done

My two cents. Worth at least double that. I believe we are on much better ground. However I do have some concerns which will not be resolved until a deal is done. This team has failed to add a ...more

179

Comment by Trogarzonon Apr 11, 2024 12:44pm

RE:RE:Dilutions

Also.. but after what we have been trough... I do not beleive anything they say anymore... remember the story of the 3 little pigs.....

Discussion

Comment by Mannequinon Apr 11, 2024 12:03pm

RE:Dilutions

I beleive they can only pay off $40M starting July. So not too certain that they need to raise too much to do that. And, if they did a partnership with $20M, they would have enough. ...more

101

Discussion

Comment by Trogarzonon Apr 11, 2024 12:00pm

RE:Dilutions

They should merge with some cash rich biotech like Repare Therapeutics that has 225M in cash and just lost its onco partner not so long ago. A merge of equals could pay the dept and provide them ...more

Discussion

Post by Trogarzonon Apr 11, 2024 10:21am

Dilutions

With sales all over the place in Q1 I would'nt be surprise they throw us under the bus one last time in order to get reelected of course and justify the use of proceeds by dept repayment and ...more

118

Discussion

Comment by Trogarzonon Apr 11, 2024 9:57am

RE:Strong negociation position quote from our CEO

That is like advertising that you welcome anyone to accompany you at the prom night a week before... won't end up with the prom Queen.

Discussion

Post by Trogarzonon Apr 11, 2024 8:17am

Strong negociation position quote from our CEO

Putting up the banner.... “We welcome discussions with potential partners interested in helping to advance development of this novel peptide-drug conjugate.”

120

Discussion